Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis

Atrial Fibrillation Begets Atrial Fibrillation

WIJFFELS, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,500 · see citing works

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.

Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033 · see citing works

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

Hansson, L., Lindholm, L. H., NISKANEN, L. K., Lanke, J., Hedner, T., Niklason, A., LUOMANMÄKI, K., Dahlöf, B., Fairé, U. D., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 1,991 · see citing works

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

Hansson, L., Lindholm, L. H., Ekbom, T., Dahlöf, B., Lanke, J., Scherstén, B., Wester, P.-O., Hedner, T., & Fairé, U. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10327-1 · Cited by 1,442 · see citing works

The Study on Cognition and Prognosis in the Elderly (SCOPE)

Lithell, H., Hansson, L., Skoog, I. G., Elmfeldt, D., Albert Hofman, D., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00011 · Cited by 1,413 · see citing works

Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation

Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M. A., & Maseri, A. (1997) · Circulation · doi:10.1161/01.cir.96.4.1180 · Cited by 1,400 · see citing works

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,358 · see citing works

Promotion of Atrial Fibrillation by Heart Failure in Dogs

Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,343 · see citing works

GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction

GRUPPOITALIANOPERLOSTUDIODELL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90232-1 · Cited by 1,115 · see citing works

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

Wachtell, K., Lehto, M., Gerdts, E., Olsen, M. H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen, S. E., Lindholm, L. H., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.068 · Cited by 826 · see citing works

Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

Healey, J. S., Baranchuk, A., Crystal, E., Morillo, C. A., Garfinkle, M., Yusuf, S., & Connolly, S. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.070 · Cited by 822 · see citing works

Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure

Li, D., Shinagawa, K., Pang, L., Leung, T. K., Cardin, S., Wang, Z., & Nattel, S. (2001) · Circulation · doi:10.1161/hc4601.099402 · Cited by 702 · see citing works

Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study

Madrid, A. H., Bueno, M. G., Rebollo, J. M. G., Marín, I., Peña, G., Bernal, E., Rodriguez, A., Cano, L., Cano, J. M., Cabeza, P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000022665.18619.83 · Cited by 685 · see citing works

Acc/aha/esc guidelines for the management of patients with atrialfibrillation: executive summary a report of the american college ofcardiology/american heart association task force on practice guideli

Fúster, & Westerling, R. (2001) · Circulation · Cited by 607 · see citing works

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Circulation · doi:10.1161/circ.104.17.2118 · Cited by 607 · see citing works

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

Weber, M. A., Julius, S., Kjeldsen, S. E., Brunner, H. R., Ekman, S., Hansson, L., Hua, T. A., Laragh, J. H., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16456-8 · Cited by 591 · see citing works

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

Goette, A., Staack, T., Röcken, C., Arndt, M., Geller, J. C., Huth, C., Ansorge, S., Klein, H. U., & Lendeckel, U. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00611-2 · Cited by 583 · see citing works

Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction

Vermès, E., Tardif, J., Bourassa, M. G., Racine, N., Lévesque, S., White, M., Guerra, P. G., & Ducharme, A. (2003) · Circulation · doi:10.1161/01.cir.0000072793.81076.d4 · Cited by 577 · see citing works

Effects of Atrial Dilatation on Refractory Period and Vulnerability to Atrial Fibrillation in the Isolated Langendorff-Perfused Rabbit Heart

Ravelli, F., & Allessie, M. A. (1997) · Circulation · doi:10.1161/01.cir.96.5.1686 · Cited by 478 · see citing works

Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation

Nakashima, H., Kumagai, K., Urata, H., Gondo, N., Ideishi, M., & Arakawa, K. (2000) · Circulation · doi:10.1161/01.cir.101.22.2612 · Cited by 443 · see citing works

Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation.

Wijffels, M., Kirchhof, C., Dorland, R., Power, J., & Allessie, M. (1997) · Circulation · doi:10.1161/01.cir.96.10.3710 · Cited by 399 · see citing works

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

Ueng, K. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.014 · Cited by 293 · see citing works

Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data

Pizzetti, F., Turazza, F. M., Franzosi, M. G., Barlera, S., Ledda, A., Maggioni, A. P., Santoro, L., & Tognoni, G. (2001) · Heart · doi:10.1136/heart.86.5.527 · Cited by 285 · see citing works

Regulation of Angiotensin II Receptor Subtypes During Atrial Fibrillation in Humans

Goette, A., Arndt, M., Röcken, C., Spiess, A., Staack, T., Geller, J. C., Huth, C., Ansorge, S., Klein, H., & Lendeckel, U. (2000) · Circulation · doi:10.1161/01.cir.101.23.2678 · Cited by 280 · see citing works

The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction

Pedersen, O. B. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1352 · Cited by 230 · see citing works

Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion

Sun, Y. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00097-7 · Cited by 230 · see citing works

Effect of enalapril on ventricular arrhythmias in congestive heart failure

Webster, M. W. I., Fitzpatrick, M. A., Nicholls, M. G., Ikram, H., & Wells, J. E. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)91186-5 · Cited by 184 · see citing works

Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery

Goette, A. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00251-1 · Cited by 179 · see citing works

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation

L’Allier, P. L., Ducharme, A., Keller, P., Yu, H., Guertin, M., & Tardif, J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.056 · Cited by 170 · see citing works

Cell Type–Specific Angiotensin II–Evoked Signal Transduction Pathways

Zou, Y., Komuro, I., Yamazaki, T., Kudoh, S., Aikawa, R., Zhu, W., Shiojima, I., Hiroi, Y., Tobe, K., Kadowaki, T., et al. (1998) · Circulation Research · doi:10.1161/01.res.82.3.337 · Cited by 145 · see citing works

Effects of lisinopril in patients with heart failure and chronic atrial fibrillation

van den Berg, M. P., CRUNS, H. J. G. M., van Veldhuisen, D. J., Griep, N., de Kam, P. J., & Lie, K. I. (1995) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(05)80004-1 · Cited by 111 · see citing works

Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation

Goette, A., Hoffmanns, P., Enayati, W., Meltendorf, U., Geller, J. C., & Klein, H. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01905-1 · Cited by 107 · see citing works

Differential Activation of Cardiac c-Jun Amino-Terminal Kinase and Extracellular Signal-Regulated Kinase in Angiotensin II–Mediated Hypertension

Yano, M., Kim, S., Izumi, Y., Yamanaka, S., & Iwao, H. (1998) · Circulation Research · doi:10.1161/01.res.83.7.752 · Cited by 97 · see citing works

Localization of angiotensin AT1 and AT2 receptors.

Allen, A. M., Zhuo, J. L., & Mendelsohn, F. A. O. (1999) · PubMed · Cited by 82 · see citing works

Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system

Kolb, C., Nürnberger, S., Ndrepepa, G., Zrenner, B., Schömig, A., & Schmitt, C. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01891-4 · Cited by 75 · see citing works

Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation

Zaman, A., Kearney, M. T., Schecter, C., Worthley, S. G., & Nolan, J. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.07.027 · Cited by 71 · see citing works

Cytosolic Calcium Changes Induced by Angiotensin II in Neonatal Rat Atrial and Ventricular Cardiomyocytes Are Mediated via Angiotensin II Subtype 1 Receptors

Touyz, R. M., Sventek, P., Larivière, R., Thibault, G., Fareh, J., Reudelhuber, T. L., & Schiffrin, E. L. (1996) · Hypertension · doi:10.1161/01.hyp.27.5.1090 · Cited by 47 · see citing works

Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction

Alsheikh-Ali, A. A. A., Wang, P. J., Rand, W., Konstam, M. A., Homoud, M. K., Link, M. S., Estes, N. A. M., Salem, D. N., & Al‐Ahmad, A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.12.033 · Cited by 46 · see citing works

Angiotensin-Converting Enzyme Inhibitor Therapy Inhibits the Progression From Paroxysmal Atrial Fibrillation to Chronic Atrial Fibrillation

Hirayama, Y., Atarashi, H., Kobayashi, Y., Horie, T., Iwasaki, Y., Maruyama, M., Miyauchi, Y., Ohara, T., Yashima, M., & Takano, T. (2005) · Circulation Journal · doi:10.1253/circj.69.671 · Cited by 45 · see citing works

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation

Noord, T. V., Crijns, H. J. G. M., van den Berg, M. P., van Veldhuisen, D. J., & Gelder, I. C. V. (2005) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-5-3 · Cited by 37 · see citing works

1145-122 Prevention of atrial fibrillation in symptomatic chronic heart failure by candesartan: Results from CHARM

Swedberg, K. B., Pfeffer, M. A., Solal, A. C., Ducharme, A., Granger, C. B., Michelson, E. L., McMurray, J. J. V., Young, J. D., & Yusuf, S. (2004) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(04)90941-2 · Cited by 32 · see citing works

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

Ueng, K.-C., Tsai, T. P., & Yu, W. C. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.03.015 · Cited by 26 · see citing works

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,119 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418 · see citing works

Guidelines for the management of atrial fibrillation

Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,875 · see citing works

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955 · see citing works

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000040 · Cited by 2,056 · see citing works

Guidelines for the management of atrial fibrillation

Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · EP Europace · doi:10.1093/europace/euq350 · Cited by 1,749 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403 · see citing works

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.021 · Cited by 574 · see citing works

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

Savelieva, I., Kakouros, N., Kourliouros, A., & Camm, A. J. (2011) · EP Europace · doi:10.1093/europace/eur002 · Cited by 311 · see citing works

New antiarrhythmic drugs for treatment of atrial fibrillation

Dobrev, D., & Nattel, S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60096-7 · Cited by 284 · see citing works

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

Khan, N. A., Hemmelgarn, B. R., Padwal, R. S., Larochelle, P. M., Mahon, J. L., Lewanczuk, R. Z., McAlister, F. A., Rabkin, S. W., Hill, M. D., Feldman, R. D., et al. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70798-5 · Cited by 109 · see citing works

2020 Clinical guidelines for Atrial fibrillation and atrial flutter

Arakelyan, M. S., Bockeria, L. A., Vasilieva, E., Sp, G., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Станиславовна, К. Е., Kuchinskaya, Е. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 255 · see citing works

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

Khan, N. A., Hemmelgarn, B. R., Herman, R. J., Rabkin, S. W., McAlister, F. A., Bell, C. M., Touyz, R. M., Padwal, R. S., Leiter, L. A., Mahon, J. L., et al. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70620-2 · Cited by 219 · see citing works

Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension

Manolis, A. J., Rosei, E. A., Coca, A., Cifkova, R., Erdine, S. E., Kjeldsen, S., Lip, G. Y. H., Narkiewicz, K., Parati, G., Redon, J., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834f03bf · Cited by 198 · see citing works

Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections

Stefansdottir, H., Aspelund, T., Gudnason, V. G., & Arnar, D. O. (2011) · EP Europace · doi:10.1093/europace/eur132 · Cited by 182 · see citing works

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Savelieva, I., Kakouros, N., Kourliouros, A., & Camm, A. J. (2011) · EP Europace · doi:10.1093/europace/eur023 · Cited by 160 · see citing works

Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Clinical Outcome in Patients Undergoing Coronary Artery Bypass Grafting

Miceli, A., Capoun, R., Fino, C., Narayan, P., Bryan, A. J., Angelini, G. D., & Caputo, M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.008 · Cited by 155 · see citing works

2018 Korean Guideline of Atrial Fibrillation Management

Joung, B., Lee, J., Lee, K. H., Kim, T., Choi, E., Lim, W., Kang, K., Uhm, J., Lim, H. E., Park, J., et al. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0339 · Cited by 154 · see citing works

Atrial Fibrillation in the 21st Century: A Current Understanding of Risk Factors and Primary Prevention Strategies

Menezes, A. R., Lavie, C. J., DiNicolantonio, J. J., O’Keefe, J. H., Morin, D. P., Khatib, S., & Milani, R. V. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.01.022 · Cited by 136 · see citing works

Atrial fibrosis and atrial fibrillation: The role of the TGF-β1 signaling pathway

Gramley, F., Lorenzen, J., Koellensperger, E., Kettering, K., Weiß, C. H., & Münzel, T. F. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.03.110 · Cited by 127 · see citing works

n-3 Polyunsaturated Fatty Acids in the Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion

Nodari, S., Triggiani, M., Campia, U., Manerba, A., Milesi, G., Cesana, B. M., Gheorghiade, M., & Cas, L. D. (2011) · Circulation · doi:10.1161/circulationaha.111.022194 · Cited by 111 · see citing works

Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies

Crandall, M. A., Bradley, D. J., Packer, D. L., & Asirvatham, S. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.7.643 · Cited by 79 · see citing works

Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels

Ogunsua, A., Shaikh, A. Y., Ahmed, M., & McManus, D. D. (2015) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-11-4-228 · Cited by 77 · see citing works

Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery

Cardinale, D. M., Sandri, M. T., Colombo, A., Salvatici, M., Tedeschi, I., Bacchiani, G., Beggiato, M., Meroni, C. A., Civelli, M., Lamantia, G., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001626 · Cited by 70 · see citing works

2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter

Heidenreich, P. A., Solis, P., Estes, N. A. M., Fonarow, G. C., Jurgens, C. Y., Marine, J. E., McManus, D. D., & McNamara, R. L. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000018 · Cited by 62 · see citing works

2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter

Heidenreich, P. A., Solis, P., Estes, N. A. M., Fonarow, G. C., Jurgens, C. Y., Marine, J. E., McManus, D. D., & McNamara, R. L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.521 · Cited by 58 · see citing works

Effects of angiotensin II receptor blockers on dementia

Mogi, M., & Horiuchi, M. (2009) · Hypertension Research · doi:10.1038/hr.2009.110 · Cited by 54 · see citing works

Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction — A meta analysis of 7 prospective clinical studies

Fu, M., Zhou, J., Sun, A., Zhang, S., Zhang, C., Zou, Y., Fu, M. L. X., & Ge, J. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.01.081 · Cited by 54 · see citing works

Role of Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Aldosterone Antagonists in the Prevention of Atrial and Ventricular Arrhythmias

Makkar, K. M., Sanoski, C. A., & Spinler, S. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.1.31 · Cited by 53 · see citing works

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis

Huang, G., Xu, J., Liu, J., He, Y., Nie, X.-L., Li, Q., Hu, Y., Zhao, S.-Q., Wang, M., Zhang, W., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02460.x · Cited by 51 · see citing works

Antiarrhythmic therapy in atrial fibrillation

Ravens, U. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.004 · Cited by 48 · see citing works

The programmed aging paradigm: How we get old

Libertini, G. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914100034 · Cited by 46 · see citing works

Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice

Suo, Y., Yuan, M., Li, H., Zhang, Y., Li, Y., Fu, H., Han, F., Ma, C., Wang, Y., Bao, Q., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01285 · Cited by 46 · see citing works

The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females

Patel, D., Mohanty, P. K., Biase, L. D., Wang, Y., Shaheen, M., Sanchez, J. E., Horton, R., Gallinghouse, G., ZAGRODZKY, J. D., Bailey, S., et al. (2010) · EP Europace · doi:10.1093/europace/eup387 · Cited by 45 · see citing works

The Role of Renin–Angiotensin System Blockade Therapy in the Prevention of Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Zhang, Y., Zhang, P., Mu, Y., Gao, M., WANG, J., Wang, Y., Su, L., & Hou, Y. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.123 · Cited by 45 · see citing works

Outcomes of Preoperative Angiotensin-Converting Enzyme Inhibitor Therapy in Patients Undergoing Isolated Coronary Artery Bypass Grafting

Bandeali, S. J., Kayani, W. T., Lee, V., Pan, W., Elayda, M. A. A., Nambi, V., Jneid, H. M., Alam, M., Wilson, J. M., Birnbaum, Y., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.05.021 · Cited by 39 · see citing works

Prevention of atrial fibrillation with renin-angiotensin system inhibitors on essential hypertensive patients: a meta-analysis of randomized controlled trials

Zhao, D., Wang, Z., & Wang, L. (2015) · Journal of Biomedical Research · doi:10.7555/jbr.29.20140149 · Cited by 38 · see citing works

The Role Of Renin Angiotensin System In Atrial Fibrillation.

Nair, G. M., Nery, P. B., Redpath, C. J., & Birnie, D. H. (2014) · PubMed Central · doi:10.4022/jafib.972 · Cited by 38 · see citing works

2025 Clinical practice guidelines for Atrial fibrillation and flutter

Golukhova, E. Z., Sp, G., Михайлов, Е. Н., Revishvili, A. S. H., Arakelyan, M. G., Vasilyeva, E. Y., Davtyan, K. V., Drapkina, O. M., Drozdova, L. Y., Станиславовна, К. Е., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6668 · Cited by 44 · see citing works

Virtual Screening Targeting the Urokinase Receptor, Biochemical and Cell-Based Studies, Synthesis, Pharmacokinetic Characterization, and Effect on Breast Tumor Metastasis

Wang, F., Li, J., Sinn, A. L., Knabe, W. E., Khanna, M., Jo, I., Silver, J. M., Oh, K., Li, L., Sandusky, G. E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200782y · Cited by 35 · see citing works

Assessment of atrial fibrosis for the rhythm control of atrial fibrillation

Begg, G. A., Holden, A. V., Lip, G. Y. H., Plein, S., & Tayebjee, M. H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.144 · Cited by 33 · see citing works

Elevations in serum creatinine with RAAS blockade: why isnʼt it a sign of kidney injury?

Ryan, M. J., & Tuttle, K. R. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32830a9606 · Cited by 30 · see citing works

Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS–ERK and PI3K–Akt–eNOS pathways in spontaneously hypertensive rats

Wang, W., Zhang, F., Chen, J., Chen, X., Fu, F., Tang, M., & Chen, L. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0416 · Cited by 30 · see citing works

Atrial fibrillation and inflammation

Özaydın, M. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i8.243 · Cited by 29 · see citing works

Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension

Akioyamen, L. E., Levine, M., Sherifali, D., O’Reilly, D. J., Frankfurter, C., Pullenayegum, E., Goeree, R. A., & Tsoi, B. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.11.005 · Cited by 28 · see citing works

Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology

Fabiani, I., Colombo, A., Bacchiani, G., Cipolla, C. M., & Cardinale, D. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010037 · Cited by 26 · see citing works

Cardiometabolic Risk Factors and Atrial Fibrillation

Menezes, A. R., Lavie, C. J., DiNicolantonio, J. J., O’Keefe, J. H., Morin, D. P., Khatib, S., Messerli, F. H., & Milani, R. V. (2013) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0693 · Cited by 25 · see citing works

Renin–angiotensin–aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy

Huang, C., Yang, Y., Lin, L., Tsai, C., Hwang, J., Chen, P., & Lin, J.-L. (2018) · Heart · doi:10.1136/heartjnl-2017-312573 · Cited by 23 · see citing works

Hypertension associated with atrial fibrillation

Aronow, W. S. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.10.33 · Cited by 21 · see citing works

Predictors of incident atrial fibrillation and influence of medications: a retrospective case–control study

Hodgkinson, J., Taylor, C. J., & Hobbs, R. F. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x578034 · Cited by 21 · see citing works

Treatment of Long-Lasting Persistent Atrial Fibrillation Using Minimally Invasive Surgery Combined With Irbesartan

Wang, J., Li, Y., Shi, J., Han, J., Cui, Y., Luo, T., & Xu, M. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.11.063 · Cited by 20 · see citing works

EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION

Sp, G., Панченко, Е. П., Станиславовна, К. Е., Laiovich, L. I., Maykov, E. B., Mironov, N. Y., & Shakhmatova, O. O. (2019) · Eurasian heart journal · doi:10.38109/2225-1685-2019-4-4-85 · Cited by 21 · see citing works

Clinical U pdate on the M anagement of A trial F ibrillation

Danelich, I. M., Reed, B. N., Hollis, I. B., Cook, A. M., & Rodgers, J. E. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1217 · Cited by 20 · see citing works

Review: Beyond the Guidelines: New and Novel Agents for the Prevention of Atrial Fibrillation After Cardiothoracic Surgery

Reinhart, K. M., Baker, W. L., & Siv, M. L.-W. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410378120 · Cited by 19 · see citing works

Inflammation pathways as therapeutic targets in angiotensin II induced atrial fibrillation

Hou, A., Shi, D., Huang, H., Liu, Y., & Zhang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1515864 · Cited by 16 · see citing works

Inhibition of the Renin-Angiotensin System for Prevention of Atrial Fibrillation

Zografos, T. A., & Katritsis, D. G. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02832.x · Cited by 15 · see citing works

Manejo de los pacientes con fibrilación auricular en los servicios de urgencias hospitalarios (actualización 2012)

Martı́n, A., Lozano, I. F., Puig, B. C.-V., Tercedor, L., del Arco, C., Ynsaurriaga, F. A., Méndez, C. S., & Girbau, L. M. (2012) · Emergencias · Cited by 14 · see citing works

Atrial Fibrillation and Hypertension: “Quo Vadis”

Kwon, Y., Walker, M., Patel, P., Kwon, O., Koene, R. J., & Duprez, D. A. (2022) · Current Hypertension Reviews · doi:10.2174/1573402118666220112122403 · Cited by 15 · see citing works

Use of Angiotensin‐Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy to Reduce Cardiovascular Events in High‐Risk Patients: Part 1

Bommer, W. J. (2008) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.08435.x · Cited by 13 · see citing works

Upstream Effect for Atrial Fibrillation: Still a Dilemma?

Calò, L., Martino, A., Sciarra, L., Ciccaglioni, A., Ruvo, E. D., Luca, L. D., Sette, A., Giunta, G., Lioy, E., & Fedele, F. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02942.x · Cited by 13 · see citing works

Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis

Lin, T., Chiang, J., Liao, M., Tsai, C., Hwang, J., Chiang, F., Lin, J.-L., & Lin, L. (2015) · Scientific Reports · doi:10.1038/srep17731 · Cited by 12 · see citing works

Inhibition of the renin-angiotensin-aldosterone system prevents and cures atrial fibrillation

Yu, Z., Zhang, D., Ji, Q.-H., & Yi, F. (2021) · Medicine · doi:10.1097/md.0000000000025559 · Cited by 12 · see citing works

Blood pressure in patients with atrial fibrillation: part 2—treatment

Cohen, D. L., & Townsend, R. R. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12939 · Cited by 10 · see citing works

Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit

Anderson, S. G., Shoaib, A., Myint, P. K., Cleland, J. G. F., Hardman, S. M. C., McDonagh, T. A., Dargie, H., Keavney, B. D., Garratt, C. J., & Mamas, M. A. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01463-5 · Cited by 10 · see citing works

Atrial Fibrillation and the Renin-Angiotensin-Aldosterone System

Perlini, S., Belluzzi, F., Salinaro, F., & Musc, F. (2013) · InTech eBooks · doi:10.5772/53917 · Cited by 9 · see citing works

Atrial fibrillation and arterial hypertension

Баранова, Е. И. (2011) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2011--4- · Cited by 9 · see citing works

Adjuvant Therapy for Atrial Fibrillation

Mohammed, K., Kowey, P. R., & Musco, S. (2009) · Future Cardiology · doi:10.2217/fca.09.57 · Cited by 8 · see citing works

Upstream Therapy for Atrial Fibrillation in Heart Failure

Goette, A. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.010 · Cited by 8 · see citing works

Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke?

Solun, B., Marcoviciu, D., & Dicker, D. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.07.001 · Cited by 8 · see citing works

Eurasian clinical guidelines for the diagnosis and treatment of atrial fibrillation in adult patients (2025)

Sp, G., Панченко, Е. П., Mironov, N. Y., Михайловна, Б. М., Gagloeva, D. A., Elfimova, E. M., Станиславовна, К. Е., Laiovich, L. I., Litvin, A. Y., Maykov, E. B., et al. (2025) · Eurasian heart journal · doi:10.38109/2225-1685-2025-3-6-77 · Cited by 8 · see citing works

Focus on renin–angiotensin system modulation and atrial fibrillation control after GISSI AF results

Durin, O., Pedrinazzi, C., & Inama, G. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32833cdd6f · Cited by 7 · see citing works

Elevations in serum creatinine with RAAS blockade: why isnʼt it a sign of kidney injury?

Ryan, M. J., & Tuttle, K. R. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e32831daeff · Cited by 6 · see citing works

A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: a pilot study

Vincenti, A., Rota, M., Spinelli, M., Corciulo, M., Ceglia, S. D., Rovaris, G., Antolini, L., & Genovesi, S. (2011) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2011.08.005 · Cited by 6 · see citing works

Renin-Angiotensin System and AtrialFibrillation:Understanding the Connection.

Disertori, M., & Quintarelli, S. (2011) · Europe PMC (PubMed Central) · doi:10.4022/jafib.398 · Cited by 5 · see citing works

Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2

Rivard, L., Samuel, M., Fortier, A., Guertin, M., Khairy, P., Roy, D., Talajic, M. R., & Tardif, J. (2021) · CJC Open · doi:10.1016/j.cjco.2021.04.014 · Cited by 4 · see citing works

Primary Prevention of Atrial Fibrillation where are we in 2012?

Imazio, M. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.608 · Cited by 4 · see citing works

Nebivolol and quinapril reduce p-wave duration and dispersion in hypertensive patients.

Korkmaz, H., Önalan, O., Akbulut, M., & Özbay, Y. (2009) · PubMed Central · Cited by 4 · see citing works

New insight into the association among atrial fibrillation, electrophysiological remodeling, and the ACE insertion/deletion polymorphism—Toward a more patient-tailored therapy?

van den Berg, M. P., & Gelder, I. C. V. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.06.008 · Cited by 4 · see citing works

Meta-analysis of renin angiotensin aldosterone modulators mitigating atrial fibrillation risk in hypertensive patients

Mahadevan, A., Garikipati, S., Vanani, S., Sundaram, D. M., Thompson‐Edwards, A., Reyaz, N., Babu, K., Rajarajan, S., Dhavapalani, D., Anand, D. P., et al. (2024) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2024.07.016 · Cited by 3 · see citing works

The Efficacy and Tolerability of Commonly Used Agents to Prevent Recurrence of Atrial Fibrillation After Successful Cardioversion

Gonna, H., & Gallagher, M. M. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-014-0064-5 · Cited by 3 · see citing works

2018 Korean Heart Rhythm Society Guidelines for Detection and Management of Risk Factors and Concomitant Cardiovascular Diseases in Korean Patients with Atrial Fibrillation

Lee, S., Lee, Y. S., Lim, W., Kim, T., Cha, M., Lee, J. H., Baek, Y., Lim, H. E., Joung, B., Kim, J. S., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.4.324 · Cited by 2 · see citing works

Atrial Fibrillation: Upstream Therapies

Kourliouros, A., Savelieva, I., Jahangiri, M., & Camm, A. J. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch36 · Cited by 2 · see citing works

ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery

Knobloch, K., Gohritz, A., Spies, M., & Vogt, P. M. (2008) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2007.174698a · Cited by 2 · see citing works

Cardiología (ESC) Desarrolladas con la contribución especial de European Heart Rhythm Association (EHRA) Aprobado por European Association for Cardio-Thoracic Surgery (EACTS)

Camm, A. J., Kirchhof, P. F., Ernst, S., Gelder, I. C. V., Hindricks, G., Heidbüchel, H., Colonna, P., Goette, A., Hohloser, S. H., Kolh, P. H., et al. (2010) · Cited by 2 · see citing works

Advances in the management of atrial fibrillation

Li, A. C., & Behr, E. R. (2012) · Clinical Medicine · doi:10.7861/clinmedicine.12-6-544 · Cited by 1 · see citing works

Advances in the Treatment of Atrial Fibrillation Complicated with Hypertension by Traditional Chinese Medicine and Western Medicine

杨, 胜. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14112839 · Cited by 1 · see citing works

Atrial fibrillation in diabetes: A cause for concern?

Szwejkowski, B. R., Rekhraj, S., Morris, A. D., & Struthers, A. D. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.24059 · Cited by 1 · see citing works

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

Khan, N. A., Hemmelgarn, B. R., Herman, R. J., Bell, C. M., Mahon, J. L., Leiter, L. A., Rabkin, S. W., Hill, M. D., Padwal, R. S., Touyz, R. M., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70492-1 · Cited by 2 · see citing works

Prévalence de la fibrillation atriale non valvulaire et de l´accident vasculaire cérébral ischémique et facteurs associés à la fibrillation atriale non valvulaire chez les patients hypertendus: étude observationnelle à propos de 2887 patients

Bahloul, A., Bouattour, N., Triki, F., Hammami, R., Charfeddine, S., Ellouze, T., Mhiri, C., Abid, L., & Kammoun, S. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.38.31.25569 · Cited by 1 · see citing works

Atrial Fibrillation and Heart Failure in the Aging Population

Kazemian, P., & Jugdutt, B. I. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0268-2_5

International differences in the clinical effectiveness of medical interventions: a study using “panoramic” meta-analysis

Hartley, L. (2012) · University of Birmingham Institutional Research Archive (University of Birmingham)

1 Hypertensie: definitie en achtergronden

van den Born, B. H., Potkamp, J. J., & van Montfrans, G. A. (2010) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7372-7_1

Upstream Therapy in the Treatment of Atrial Fibrillation

Băicuş, C. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5475-4_4

Valsartan and Amlodipine: Safety and Efficacy in Stroke Prevention

Ichihara, K. B. A. A. (2010) · Clinical Medicine Reviews in Vascular Health · doi:10.4137/cmrvh.s5204

ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery

Raja, S. G. (2008) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2007.174698a1

A multistudy analysis investigating systematic differences in cardiovascular trial results between Europe and Asia

Hartley, L., Girling, A. J., Bowater, R. J., & Lilford, R. J. (2014) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2013-203646

Treatment with renin-angiotensin-aldosterone system inhibitors and the decrease in inflammatory markers in paroxysmal atrial fibrillation.

Roşianu, Ş. H., Roşianu, A., Aldica, M., Capalneanu, R., & Buzoianu, A. D. (2013)

Plasma Angiotensin Converting Enzyme Level and Permanent Atrial Fibrillation with Mitral Valvular Disease

Qian, Y., Hanzhang, S., Luo, T.-X., Dongmin, W., Xiang, B., Jun, M., & Xiao, X. (2008) · Zhongguo xiong-xin xueguan waike linchuang zazhi

Welche kardiale Diagnostik braucht Ihr Hypertoniker?

Ukena, C., Mahfoud, F., & Böhm, M. (2014) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-014-3214-4

REVIEW Inhibition of the Renin-Angiotensin System for Prevention of Atrial Fibrillation

Zografos, T. A., Katritsis, D. G., & Ph., D. (2016)

Inhibition of the Renin-Angiotensin System for Prevention of Atrial Fibrillation

Zografos, T. A., & Katritsis, D. G. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02832.x · Cited by 15 · see citing works

The Role of Renin–Angiotensin System Blockade Therapy in the Prevention of Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Zhang, Y., Zhang, P., Mu, Y., Gao, M., WANG, J., Wang, Y., Su, L., & Hou, Y. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.123 · Cited by 45 · see citing works

Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials

Khatib, R., Joseph, P., Briel, M., Yusuf, S., & Healey, J. S. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.02.009 · Cited by 125 · see citing works

The Impact of Suppressing the Renin‐Angiotensin System on Atrial Fibrillation

Kalus, J. S., Coleman, C. I., & White, C. M. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005283284 · Cited by 59 · see citing works